Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Fusion of CCL21 non-migratory active breast epithelial and breast cancer cells give rise to CCL21 migratory active tumor hybrid cell lines.

Berndt B, Haverkampf S, Reith G, Keil S, Niggemann B, Zänker KS, Dittmar T.

PLoS One. 2013 May 7;8(5):e63711. doi: 10.1371/journal.pone.0063711. Print 2013.

2.

Characterization of hybrid cells derived from spontaneous fusion events between breast epithelial cells exhibiting stem-like characteristics and breast cancer cells.

Dittmar T, Schwitalla S, Seidel J, Haverkampf S, Reith G, Meyer-Staeckling S, Brandt BH, Niggemann B, Zänker KS.

Clin Exp Metastasis. 2011 Jan;28(1):75-90. doi: 10.1007/s10585-010-9359-3. Epub 2010 Oct 28.

PMID:
20981475
3.

Hybrid clone cells derived from human breast epithelial cells and human breast cancer cells exhibit properties of cancer stem/initiating cells.

Gauck D, Keil S, Niggemann B, Zänker KS, Dittmar T.

BMC Cancer. 2017 Aug 2;17(1):515. doi: 10.1186/s12885-017-3509-9.

4.

CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.

Zhang L, Wang D, Li Y, Liu Y, Xie X, Wu Y, Zhou Y, Ren J, Zhang J, Zhu H, Su Z.

PLoS One. 2016 Aug 9;11(8):e0158529. doi: 10.1371/journal.pone.0158529. eCollection 2016.

5.

Lipopolysaccharide (LPS) Promotes Apoptosis in Human Breast Epithelial × Breast Cancer Hybrids, but Not in Parental Cells.

Fried S, Tosun S, Troost G, Keil S, Zaenker KS, Dittmar T.

PLoS One. 2016 Feb 10;11(2):e0148438. doi: 10.1371/journal.pone.0148438. eCollection 2016.

6.

The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.

Tutunea-Fatan E, Majumder M, Xin X, Lala PK.

Mol Cancer. 2015 Feb 10;14:35. doi: 10.1186/s12943-015-0306-4.

7.

Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors.

Weitzenfeld P, Kossover O, Körner C, Meshel T, Wiemann S, Seliktar D, Legler DF, Ben-Baruch A.

J Leukoc Biol. 2016 Jun;99(6):1009-25. doi: 10.1189/jlb.3MA0815-373R. Epub 2016 Mar 2.

PMID:
26936935
8.

CCL21/CCR7 axis activating chemotaxis accompanied with epithelial-mesenchymal transition in human breast carcinoma.

Li F, Zou Z, Suo N, Zhang Z, Wan F, Zhong G, Qu Y, Ntaka KS, Tian H.

Med Oncol. 2014 Sep;31(9):180. doi: 10.1007/s12032-014-0180-8. Epub 2014 Aug 21.

PMID:
25142946
9.

Hybrid cells derived from breast epithelial cell/breast cancer cell fusion events show a differential RAF-AKT crosstalk.

Ozel C, Seidel J, Meyer-Staeckling S, Brandt BH, Niggemann B, Zänker KS, Dittmar T.

Cell Commun Signal. 2012 Apr 9;10(1):10. doi: 10.1186/1478-811X-10-10.

10.

CCL21 modulates the migration of NSCL cancer by changing the concentration of intracellular Ca2+.

Liu J, Zhang L, Wang C.

Oncol Rep. 2012 Feb;27(2):481-6. doi: 10.3892/or.2011.1528. Epub 2011 Nov 8.

PMID:
22076436
11.

MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7.

Kim SJ, Shin JY, Lee KD, Bae YK, Sung KW, Nam SJ, Chun KH.

Breast Cancer Res. 2012 Jan 18;14(1):R14.

12.

CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells.

Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS.

Clin Cancer Res. 2004 Apr 1;10(7):2351-8.

13.

Combinatorial guidance by CCR7 ligands for T lymphocytes migration in co-existing chemokine fields.

Nandagopal S, Wu D, Lin F.

PLoS One. 2011 Mar 25;6(3):e18183. doi: 10.1371/journal.pone.0018183.

14.

CCL21/CCR7 prevents apoptosis via the ERK pathway in human non-small cell lung cancer cells.

Xu Y, Liu L, Qiu X, Liu Z, Li H, Li Z, Luo W, Wang E.

PLoS One. 2012;7(3):e33262. doi: 10.1371/journal.pone.0033262. Epub 2012 Mar 16.

15.

Human eosinophils express functional CCR7.

Akuthota P, Ueki S, Estanislau J, Weller PF.

Am J Respir Cell Mol Biol. 2013 Jun;48(6):758-64. doi: 10.1165/rcmb.2012-0499OC.

16.

Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma.

Sperveslage J, Frank S, Heneweer C, Egberts J, Schniewind B, Buchholz M, Bergmann F, Giese N, Munding J, Hahn SA, Kalthoff H, Klöppel G, Sipos B.

Int J Cancer. 2012 Aug 15;131(4):E371-81. doi: 10.1002/ijc.26502. Epub 2012 Jan 11.

17.

CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1.

Shi M, Chen D, Yang D, Liu XY.

J Exp Clin Cancer Res. 2015 Dec 15;34:149. doi: 10.1186/s13046-015-0268-9.

18.

Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells.

Pan MR, Hou MF, Chang HC, Hung WC.

J Biol Chem. 2008 Apr 25;283(17):11155-63. doi: 10.1074/jbc.M710038200. Epub 2008 Mar 4.

19.

Role of the CCL21 and CCR7 pathways in rheumatoid arthritis angiogenesis.

Pickens SR, Chamberlain ND, Volin MV, Pope RM, Talarico NE, Mandelin AM 2nd, Shahrara S.

Arthritis Rheum. 2012 Aug;64(8):2471-81. doi: 10.1002/art.34452.

20.

Expression of chemokine receptor CCR7 is associated with cervical lymph node metastasis of oral squamous cell carcinoma.

Shang ZJ, Liu K, Shao Z.

Oral Oncol. 2009 Jun;45(6):480-5. doi: 10.1016/j.oraloncology.2008.06.005. Epub 2008 Aug 26.

PMID:
18752985

Supplemental Content

Support Center